N-Methyl-N-(2-pyridin-3-ylethyl)amine, 97.0%, 50mg

3,4-DIHYDRO-2H-1,4-BENZOXAZIN-6-AMINE HYDROCHLORIDE, 95%, 100mg

Ethyl 4-oxo-3-(propionyloxy)-4H-pyran-2-carboxylate, 97.0%, 5g

(6-Isopropoxypyridin-3-yl)boronic acid, 95.0%, 250mg

4-(2-Chlorophenyl)butan-2-one, 98%, 5g

3-(Methacryloxy)propyltrimethoxysilane, 98%, 500g

GC capillary column ROTI®Cap-1, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

7-BROMO-1-HYDROXYNAPHTHALENE, 95.0%, 1g

tert-butyl {[(4-methylphenyl)sulfonyl]oxy}carbamate, 95.0%, 25g

(4S)-5,8-Difluoro-3,4-dihydro-2H-1-benzopyran-4-amine hydrochloride, 97%, 1g

4-(3-Chlorophenoxy)benzoic acid, 97%, 1g

3,3-Dimethyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 250mg

Ethyl (1R,4R)-4-(dibenzylamino)cyclohexane-1-carboxylate, 97%, 500mg